comparemela.com

Latest Breaking News On - Marketbeat ratings - Page 19 : comparemela.com

CytomX Therapeutics (NASDAQ:CTMX) Stock Rating Upgraded by Piper Sandler

Piper Sandler upgraded shares of CytomX Therapeutics (NASDAQ:CTMX – Free Report) from a neutral rating to an overweight rating in a research note published on Tuesday, Marketbeat Ratings reports. The brokerage currently has $3.50 price target on the biotechnology company’s stock, up from their prior price target of $2.25. Several other equities analysts have also […]

Amgen Inc (NASDAQ:AMGN) Receives Consensus Rating of Moderate Buy from Brokerages

Amgen Inc. (NASDAQ:AMGN – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-one brokerages that are covering the stock, Marketbeat Ratings reports. Ten research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price objective among brokers […]

Imperial Oil Limited (NYSEAMERICAN:IMO) Receives $85 33 Average Price Target from Brokerages

Shares of Imperial Oil Limited (NYSEAMERICAN:IMO – Get Free Report) (TSE:IMO) have received an average recommendation of “Hold” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 […]

BRP Inc (NASDAQ:DOOO) Receives $111 75 Average PT from Brokerages

Shares of BRP Inc. (NASDAQ:DOOO – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation […]

Crescent Point Energy Corp (TSE:CPG) Receives Average Rating of Buy from Analysts

Shares of Crescent Point Energy Corp. (TSE:CPG – Get Free Report) (NYSE:CPG) have been assigned an average rating of “Buy” from the ten brokerages that are covering the firm, Marketbeat Ratings reports. Ten analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have covered the stock in […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.